|
May 2
|
Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP
|
|
Apr 29
|
ICLR vs. CRL: Which Stock Is the Better Value Option?
|
|
Apr 24
|
Charles River (CRL) to Report Q1 Earnings: Here's What to Expect
|
|
Apr 22
|
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
|
|
Apr 22
|
Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
|
|
Apr 16
|
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
|
|
Apr 12
|
ICLR or CRL: Which Is the Better Value Stock Right Now?
|
|
Apr 12
|
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
|
|
Apr 11
|
Charles River (CRL) Forges Collaboration With Ship of Theseus
|
|
Apr 11
|
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
|
|
Apr 9
|
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
|
|
Apr 4
|
Charles River to Perform Plasmid Production for Ship of Theseus
|
|
Apr 1
|
Charles River Laboratories International, Inc.'s (NYSE:CRL) Stock Is Going Strong: Is the Market Following Fundamentals?
|
|
Apr 1
|
Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
|
|
Mar 27
|
Charles River Laboratories Publishes 2023 Corporate Citizenship Report
|
|
Mar 26
|
Charles River (CRL) Extends Gene Therapy Deal With NUS Medicine
|
|
Mar 23
|
U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies
|
|
Mar 21
|
Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
|
|
Mar 15
|
Why Is Charles River (CRL) Up 6.2% Since Last Earnings Report?
|
|
Mar 15
|
Charles River (CRL) Extends Gene Therapy Offering With New Pact
|